>
Switch to:

Allergy Therapeutics 3-Year Average Share Buyback Ratio

: -3.00 (As of Jun. 2021)
View and export this data going back to 2004. Start your Free Trial

This is the average share buyback rate of the company over the past 3 years. A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

The historical rank and industry rank for Allergy Therapeutics's 3-Year Average Share Buyback Ratio or its related term are showing as below:

OTCPK:AGYTF' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -70.3   Med: -9.45   Max: -0.2
Current: -3

-70.3
-0.2

During the past years, Allergy Therapeutics's highest 3-Year Average Share Buyback Ratio was -0.20. The lowest was -70.30. And the median was -9.45.

OTCPK:AGYTF's 3-Year Average Share Buyback Ratio is ranked lower than
93% of the 127 Companies
in the Drug Manufacturers industry.

( Industry Median: -7.90 vs. OTCPK:AGYTF: -3.00 )

Allergy Therapeutics 3-Year Average Share Buyback Ratio Historical Data

The historical data trend for Allergy Therapeutics's 3-Year Average Share Buyback Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
3-Year Average Share Buyback Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Allergy Therapeutics Semi-Annual Data
Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21
3-Year Average Share Buyback Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Allergy Therapeutics's 3-Year Average Share Buyback Ratio, along with its competitors' market caps and 3-Year Average Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Allergy Therapeutics 3-Year Average Share Buyback Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, Allergy Therapeutics's 3-Year Average Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Allergy Therapeutics's 3-Year Average Share Buyback Ratio falls into.



Allergy Therapeutics 3-Year Average Share Buyback Ratio Calculation

This is the average share buyback rate of the company over the past 3 years.


Allergy Therapeutics  (OTCPK:AGYTF) 3-Year Average Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.


Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.


Allergy Therapeutics 3-Year Average Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Allergy Therapeutics's 3-Year Average Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Allergy Therapeutics Business Description

Allergy Therapeutics logo
Industry
Traded in Other Exchanges
Address
Dominion Way, Worthing, West Sussex, GBR, BN14 8SA
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergy with aluminium-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.

Allergy Therapeutics Headlines

No Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)